NEW YORK, NY / ACCESS Newswire / February 7, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Intellia ...

NEW YORK, NY / ACCESS Newswire / February 6, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Intellia ...

Detailed price information for Intellia Thera CS (NTLA-Q) from The Globe and Mail including charting and trades.

On Monday, Morgan Stanley (NYSE:MS) adjusted its stance on Intellia Therapeutics shares ... expecting to release additional data from Phase 1/2 studies within this year. Intellia is also preparing ...

On January 9 th, 2025 Intellia Therapeutics posted a press release titled “Intellia Therapeutics Announces Anticipated 2025 Milestones and Strategic Reorganization to Prioritize the Advancement ...

On Monday, Morgan Stanley (NYSE:MS) adjusted its stance on Intellia Therapeutics shares ... is prioritizing clinical execution for NTLA-2002 and nex-z, expecting to release additional data from Phase ...

Inc. ("Intellia Therapeutics, Inc.") (NASDAQ:NTLA) concerning possible violations of federal securities laws. Intellia issued a press release on January 9, 2025, "announc[ing] its strategic priorities ...

We recently compiled a list of the Cathie Wood’s Stock Portfolio: 2025 Stock Picks. In this article, we are going to take a ...

NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Intellia Therapeutics, Inc. ("Intellia" or the "Company") (NASDAQ:NTLA). Such ...

The complete 8-K filing and updates can be accessed on Intellia Therapeutics’ official website. This news release may contain forward-looking statements subject to risks and uncertainties ...

Intellia Therapeutics is starting off 2025 with a ... The Cambridge, Massachusetts-based biotech said in a release it will take an $8 million hit for the redundancies and pipeline reorganization.